Page 56 - Fluorescence-guided cancer surgery
P. 56
54
Chapter 3
25.
26.
27.
28.
29.
Millet I, Curros-Doyon F, Molinari N et al. Invasive Breast Carcinoma: In uence of Prognosis and Patient-related Factors on Kinetic MR Imaging Characteristics. Radiology 2014;270:57-66.
Clarke M, Collins R, Darby S et al. E ects of radiotherapy and of di erences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-2106.
Bloom S, Morrow M. A clinical oncologic perspective on breast magnetic resonance imaging. Magn Reson Imaging Clin N Am 2010;18:277-94.
Poortmans PM, Collette L, Horiot JC et al. Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. Radiother Oncol 2009;90:80-85.
van der Vorst JR, Schaafsma BE, Verbeek FP et al. Randomized Comparison of Near-infrared Fluorescence Imaging Using Indocyanine Green and 99(m) Technetium With or Without Patent Blue for the Sentinel Lymph Node Procedure in Breast Cancer Patients. Ann Surg Oncol 2012;19:4104-4111.
